Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis

Mohamed Elgendy, Marco Cirò, Amir Hosseini, Jakob Weiszmann, Luca Mazzarella, Elisa Ferrari, Riccardo Cazzoli, Giuseppe Curigliano, Andrea DeCensi, Bernardo Bonanni, Alfredo Budillon, Pier Giuseppe Pelicci, Veerle Janssens, Manfred Ogris, Manuela Baccarini, Luisa Lanfrancone, Wolfram Weckwerth, Marco Foiani, Saverio Minucci

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)798-815.e5
Number of pages23
JournalCancer Cell
Volume35
Issue number5
DOIs
Publication statusPublished - 2019

Austrian Fields of Science 2012

  • 301206 Pharmacology

Keywords

  • metformin
  • glucose
  • hypoglycemia
  • fasting
  • caloric restriction
  • MCL-1
  • GSK3ß
  • PP2A
  • metabolic plasticity
  • tumor metabolism
  • APOPTOSIS
  • SUPPRESSOR
  • ACTIVATION
  • KINASE
  • BREAST-CANCER PROLIFERATION
  • RESTRICTION
  • RESISTANCE
  • DEGRADATION
  • TUMORIGENESIS
  • MCL1

Fingerprint

Dive into the research topics of 'Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis'. Together they form a unique fingerprint.

Cite this